Lymphoma
Conditions
Interventions
Group 2:placebo
Sponsors
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged >= 18 years and <= 75 years, regardless of gender; 2. Primary lymphoma diagnosed by histology/cytology and imaging (including diffuse large B cell lymphoma, peripheral T cell lymphoma, NK/T cell lymphoma); 3. At least one measurable or objectively evaluable lesion on a PET/CT or CT/MRI examination; 4. Patients who can receive chemotherapy treatment.
Exclusion criteria
Exclusion criteria: 1. Supplement HMB in the short or long term; 2. Severe infection or other diseases requiring ICU treatment; 3. Poor compliance, unable to strictly follow the doctor's orders; 4. Severe renal insufficiency People who need to limit protein intake; 5. Cognitive disorders; 6. Serious mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skeletal muscle mass;weight;Muscle strength; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reaction;Incidence of sarcopenia;Completion rate of chemotherapy; | — |
Countries
China
Contacts
Public ContactJiang Wu
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Outcome results
None listed